Compare MGTX & MUC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MGTX | MUC |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 909.1M | 1.0B |
| IPO Year | 2018 | 1997 |
| Metric | MGTX | MUC |
|---|---|---|
| Price | $9.00 | $10.75 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $24.57 | N/A |
| AVG Volume (30 Days) | ★ 686.1K | 293.7K |
| Earning Date | 05-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 33.02 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $81,391,000.00 | N/A |
| Revenue This Year | $141.38 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 144.57 | N/A |
| 52 Week Low | $6.03 | $10.00 |
| 52 Week High | $11.85 | $11.04 |
| Indicator | MGTX | MUC |
|---|---|---|
| Relative Strength Index (RSI) | 44.14 | 51.54 |
| Support Level | $8.82 | $10.66 |
| Resistance Level | $9.65 | $10.87 |
| Average True Range (ATR) | 0.48 | 0.08 |
| MACD | -0.08 | 0.01 |
| Stochastic Oscillator | 5.73 | 77.63 |
MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.
BlackRock MuniHoldings California Quality Fund Inc is a diversified, closed-end management investment company. Its investment objective is to provide shareholders with current income exempt from U.S. federal income taxes and California personal income taxes. The fund mainly invests in municipal obligations exempt from U.S. federal income taxes (except that the interest may be subject to the U.S. federal alternative minimum tax) and California personal income taxes. Under normal market conditions, it invests a majority of its managed assets in investment-grade municipal obligations with remaining maturities of one year or more at the time of investment. It can also invest in below investment-grade securities, or directly in such securities or synthetically through the use of derivatives.